Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
1 CALL ON FILE
OTLK
— Outlook Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →
Q3 2024 Earnings Call Summary
AUG 14, 2024
REVENUE
$0
EPS
$1.91
+123.8%
FREE CASH FLOW
-$19.5M
-1.3%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 1
OLDER CALL →